CAS: 732278-52-3
| Marca | Dados do produto | Pureza | Gama de preços | Estimativa de entrega |
|---|---|---|---|---|
 | (R)-5-(4-Amino-3-methyl-phenyl)-8-methyl-7-(5-methyl-1,3,4-thiadiazol-2-yl)-8,9-dihydro-7H-1,3-dioxolo[4,5-H][2,3]-benzodiazepine REF: 3D-HEB27852CAS: 732278-52-3 | Min. 95% | A consultar | Ter 21 Jan 25 |
 | BDZ-g REF: TM-T62042CAS: 732278-52-3 | 98.77% | 113,00 €~1.052,00 € | Ter 11 Mar 25 |
(R)-5-(4-Amino-3-methyl-phenyl)-8-methyl-7-(5-methyl-1,3,4-thiadiazol-2-yl)-8,9-dihydro-7H-1,3-dioxolo[4,5-H][2,3]-benzodiazepine
CAS:732278-52-3
Please enquire for more information about (R)-5-(4-Amino-3-methyl-phenyl)-8-methyl-7-(5-methyl-1,3,4-thiadiazol-2-yl)-8,9-dihydro-7H-1,3-dioxolo[4,5-H][2,3]-benzodiazepine including the price, delivery time and more detailed …
Fórmula:
C21H21N5O2S
Pureza:
Min. 95%
Peso molecular:
407.5 g/mol
Ref: 3D-HEB27852
| 25mg | A consultar | ||
| 50mg | A consultar |
Entrega estimada em Estados Unidos, Terça-feira 21 de Janeiro de 2025
BDZ-g
CAS:732278-52-3
BDZ-g: potent, selective AMPA receptor antagonist; useful for researching neurological disorders.
Fórmula:
C21H21N5O2S
Pureza:
98.77%
Cor e Forma:
Liquid
Peso molecular:
407.49
Ref: TM-T62042
| 1mg | 113,00 € | ||
| 5mg | 250,00 € | ||
| 10mg | 367,00 € | ||
| 25mg | 551,00 € | ||
| 50mg | 771,00 € | ||
| 100mg | 1.052,00 € | ||
| 1mL*10mM (DMSO) | 276,00 € |
Entrega estimada em Estados Unidos, Terça-feira 11 de Março de 2025
